Physician profile
Crystal Nhieu
NPI 1912360652
$1,054.60
in general payments reported to CMS, 2019-2025
14 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.16 · 2021: $44.50 · 2022: $134 · 2023: $251 · 2024: $347 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $259.07 | 2023-2025 | |
| Exeltis, USA INC. | $256.30 | 2024-2025 | Slynd |
| Abbvie INC. | $135.93 | 2021-2023 | |
| Evofem Biosciences, INC. | $110.43 | 2023-2025 | Phexxi, Solosec, Phexx |
| Gynesonics, INC. | $61.71 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.70 | 2024-2025 | |
| Millicent US INC | $34.12 | 2023-2025 | Intrarosa, Femlyv, Femring |
| Pfizer INC. | $30.13 | 2023 | |
| Coopersurgical, INC. | $29.94 | 2022-2024 | Paragard T 380a |
| Agile Therapeutics, INC. | $23.23 | 2023 | Twirla |
| Astellas Pharma US INC | $20.71 | 2025 | Veozah |
| Therapeuticsmd, INC. | $20.16 | 2020 | |
| Sage Therapeutics, LLC | $17.93 | 2025 | Zurzuvae |
| Organon LLC | $17.24 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Nhieu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.